Home-Based System Relieves Cirrhosis Refractory Ascites
|
By HospiMedica International staff writers Posted on 11 Jan 2022 |
|
Image: An ascites patient with abdominal paracentesis scars (Photo courtesy of iStock)
A novel tunneled peritoneal catheter (PeCa) drainage system provided significant relief for patients with refractory ascites, according to a new study.
The PeCa implant, developed at Hannover Medical School (Germany), is composed of internal shut that lies in the peritoneal cavity, a tunneled section that passes through subcutaneous tissue, and an external port to which drainage bags are connected. To test system efficacy, outcomes in 152 patients with refractory ascites, who were not candidates for transjugular intrahepatic portosystemic shunt (TIPS) and received a PeCa implant, were compared to 71 patients who received standard care, which included repeated large volume paracentesis and albumin.
The results revealed that factors associated with 90-day survival were PeCa implantation, and each point of Model for End-Stage Liver Disease (MELD) score. Hospitalizations were more common in the PeCa group, for reasons that included spontaneous bacterial peritonitis (SBP), hyponatremia, and infections other than SBP. There was no significant difference in mortality between the two groups, but there were trends in the PeCa group towards higher frequency of acute kidney injury (AKI). The study was presented at the American Association for the Study of Liver Diseases annual conference, held online during November 2021.
“Patients with refractory ascites have a very high risk for rehospitalization, AKI, and death. Our data indicate that PeCa could be a valuable new treatment option for patients with refractory ascites and contraindication for TIPS,” said study co-author and presenter Tammo Lambert Tergast, MD. “I think if we can optimize the treatment after discharge, we can also minimize the rehospitalization in these patients. However, the risk for hyponatremia and AKI has to be considered and further explored.”
Refractory ascites occurs when patients no longer respond to medical therapy, a condition that affects over 100,000 patients in Europe and the United States every year, a number that is growing at approximately 10% a year. The primary treatment for ascites is paracentesis, a procedure in which a large bore needle is inserted into the patient's abdomen to remove between 5‐10 liters of ascites that has accumulated over a period of a week or two.
Related Links:
Hannover Medical School
The PeCa implant, developed at Hannover Medical School (Germany), is composed of internal shut that lies in the peritoneal cavity, a tunneled section that passes through subcutaneous tissue, and an external port to which drainage bags are connected. To test system efficacy, outcomes in 152 patients with refractory ascites, who were not candidates for transjugular intrahepatic portosystemic shunt (TIPS) and received a PeCa implant, were compared to 71 patients who received standard care, which included repeated large volume paracentesis and albumin.
The results revealed that factors associated with 90-day survival were PeCa implantation, and each point of Model for End-Stage Liver Disease (MELD) score. Hospitalizations were more common in the PeCa group, for reasons that included spontaneous bacterial peritonitis (SBP), hyponatremia, and infections other than SBP. There was no significant difference in mortality between the two groups, but there were trends in the PeCa group towards higher frequency of acute kidney injury (AKI). The study was presented at the American Association for the Study of Liver Diseases annual conference, held online during November 2021.
“Patients with refractory ascites have a very high risk for rehospitalization, AKI, and death. Our data indicate that PeCa could be a valuable new treatment option for patients with refractory ascites and contraindication for TIPS,” said study co-author and presenter Tammo Lambert Tergast, MD. “I think if we can optimize the treatment after discharge, we can also minimize the rehospitalization in these patients. However, the risk for hyponatremia and AKI has to be considered and further explored.”
Refractory ascites occurs when patients no longer respond to medical therapy, a condition that affects over 100,000 patients in Europe and the United States every year, a number that is growing at approximately 10% a year. The primary treatment for ascites is paracentesis, a procedure in which a large bore needle is inserted into the patient's abdomen to remove between 5‐10 liters of ascites that has accumulated over a period of a week or two.
Related Links:
Hannover Medical School
Gold Member
12-Channel ECG
CM1200B
Gas Analyzer
GE SAM
Medical Adhesive
MED 5570U
Latest Patient Care News
- Expert Review Outlines Diagnosis and Treatment of Recurrent Catheter Infections
- Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging
- AI Platform Personalizes Support Between Visits for Cancer Survivors
- At-Home Neuromodulation Shows Promise in Selected Patients With Hypertension
- EHR Model Flags High-Risk Periods in Patients with Metastatic Breast Cancer
- Virtual Reality Helps Claustrophobic Patients Complete Cardiac PET/CT Scans
- Weighted Blankets Reduce Anxiety in Hospitalized Adults
- Multicenter Study Quantifies Delays in Care for Emergency Department Boarders
- Real-Time Radiation Monitor Supports Safer Fluoroscopy-Guided Procedures
- FDA-Cleared Finger Cuff Device Enables Home Blood Pressure Monitoring
- AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
- Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
- Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
- VR Training Tool Combats Contamination of Portable Medical Equipment
- Portable Biosensor Platform to Reduce Hospital-Acquired Infections
- First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Channels
Artificial Intelligence
view channel
AI Tool Prioritizes Peer Referrals to Expand HIV Testing Access
Human immunodeficiency virus (HIV) remains a major public health challenge when people at risk lack timely testing and care. In South Africa, men and adolescents are among those less likely to seek testing... Read more
Explainable AI Dermoscopy Tool Supports Risk Assessment for Skin Cancer
Skin lesions can be difficult to triage when benign and malignant findings share visual features, leaving clinicians uncertain about whether to recommend biopsy or continued monitoring. These decisions... Read more
Critical Care
view channel
Chest Digital Twin Guides Light Therapy Dosing for Pneumonia
Pneumonia is a lung infection that can impair gas exchange and progress to severe respiratory compromise. Light-based therapies may help treat infection or inflammation, but externally applied light must... Read more
Intraoperative Drug Combination Reduces Kidney Injury in Septic Shock Surgery
Septic shock is a life-threatening response to infection that can cause circulatory failure and organ injury, with global mortality rates reaching 50%. Although emergency surgery can clear the underlying... Read more
Wirelessly Powered Implant Targets Excess Glucose in the Blood
Type 2 diabetes is a chronic metabolic disorder that is becoming increasingly common worldwide. It is often associated with obesity, sedentary behavior, and prolonged excess energy intake.... Read more
U.S. Launch Expands Kidney Replacement Therapy Options With Integrated Anticoagulation
Critically ill patients with acute kidney injury often require continuous kidney replacement therapy in intensive care units. During these extracorporeal treatments, careful anticoagulation management... Read moreSurgical Techniques
view channel
FDA-Cleared Thrombectomy System Removes Pulmonary Embolism Clots
Pulmonary embolism occurs when blood clots travel to the lungs and block blood flow, potentially requiring urgent endovascular intervention to prevent death. Catheter-based clot removal can be challenging,... Read more
Implantable Ultrasound Device Enhances Local Drug Delivery in Glioblastoma
Glioblastoma is an aggressive brain tumor that frequently recurs after surgery. Although surgeons can remove visible tumor tissue, residual cancer cells may remain in surrounding brain tissue and contribute... Read more
Miniature Image Sensor Enables Digital Imaging in Single-Use Endoscopes
Disposable single-use endoscopes are increasingly used to help reduce infection risk and the burden of post-procedure reprocessing and equipment management. As insertion sections become thinner, endoscopic... Read more
Half-Matched Family Donors Could Expand Transplant Access for Severe Aplastic Anemia
Severe aplastic anemia is a rare, life-threatening disorder in which the bone marrow fails to produce enough healthy blood cells, leaving children and young adults vulnerable to anemia, infection, and bleeding.... Read moreMedical Imaging
view channel
AI Approach Improves Brain MRI Lesion Detection in Epilepsy and Multiple Sclerosis
Drug-resistant epilepsy can require precise lesion localization before surgery, yet some affected patients have brain MRI scans that appear negative to physicians. Multiple sclerosis also depends on MRI... Read more
Routine CT Body Composition Tool Helps Identify Early Pancreatic Cancer Risk
Pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer, often goes undetected until it has spread. Surveillance programs primarily target people with inherited genetic risk... Read more
Health IT
view channel
Clinical Decision Support Tool Automates CKD Risk Assessment in Primary Care
Chronic kidney disease (CKD) requires timely diagnosis, risk assessment, and coordinated treatment in primary care. Delayed recognition can affect decisions about testing, blood pressure control, cardiovascular... Read more
EHR Alerts Support Dosing, Sedation, and Shock Recognition in Cardiac Care
Electronic health record alerts can add to clinician workload when they are poorly targeted. In critical cardiac care, however, delayed decisions can affect treatment timing, sedation exposure, and escalation... Read more
Point of Care
view channel
Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes
Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more
Microneedle Patch Enables At-Home Monitoring of Acute Kidney Injury
Kidney disease is often silent in its early stages, making timely detection difficult outside clinical settings. Early biomarkers such as neutrophil gelatinase–associated lipocalin can require blood draws... Read more
Business
view channel
Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal
Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Stryker Enters Soft-Tissue Robotics Through Strategic Alliance With CMR Surgical
Stryker (Portage, MI, USA) and CMR Surgical (Cambridge, UK) have announced a strategic alliance centered on the Versius Surgical Robotic portfolio. The agreement includes an approximately USD 400 million... Read more
Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma
Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more